Loading...
Loading...
Rank #45 of 69 by 3-year alpha vs SPY · mechanically replicating this book, rebalanced at filing dates
A strong clone record is a track record, not a forecast — tested across a decade it doesn't reliably repeat. See what actually holds up →
Mason Morfit leads ValueAct Capital, a constructive activist that takes concentrated stakes in a handful of companies and works with management — often from a board seat — to improve strategy and capital allocation.
COM
$559.34M
9.9% of portfolio